Selinexor, Carfilzomib, Pomalidomide, and Dexamethasone as a Salvage Regimen for Refractory and Relapsed Multiple Myeloma with Plasma-Cell Leukemia Transformation: A Case Report and Literature Review

ISSN Print: 2325-7075
ISSN Online: 2325-7083
www.scirp.net/journal/crcm
E-mail: [email protected]

Citations

"Selinexor, Carfilzomib, Pomalidomide, and Dexamethasone as a Salvage Regimen for Refractory and Relapsed Multiple Myeloma with Plasma-Cell Leukemia Transformation: A Case Report and Literature Review"
written by Yanfang Zhang, Chen Ying, Yuchen Zhang, Jianchuan Deng,
published by Case Reports in Clinical Medicine, Vol.11 No.7, 2022

has been cited by the following article(s):

[1]	The current state of knowledge about evolution of multiple myeloma to plasma cell leukemia
	Szopa… - … Lymphoma Myeloma and …, 2022